For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $53.55 in the prior trading day, Arcellx Inc (NASDAQ: ACLX) closed at $54.50, up 1.77%. In other words, the price has increased by $1.77 from its previous closing price. On the day, 0.6 million shares were traded. ACLX stock price reached its highest trading level at $54.86 during the session, while it also had its lowest trading level at $52.59.
Ratios:
Our goal is to gain a better understanding of ACLX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.60. For the most recent quarter (mrq), Quick Ratio is recorded 6.06 and its Current Ratio is at 6.06. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 07, 2024, initiated with a Overweight rating and assigned the stock a target price of $81.
On January 04, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $65 to $71.
On December 19, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $66.Scotiabank initiated its Sector Outperform rating on December 19, 2023, with a $66 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 16 ’24 when Ware Olivia C sold 9,402 shares for $55.55 per share. The transaction valued at 522,260 led to the insider holds 0 shares of the business.
Elghandour Rami sold 23,086 shares of ACLX for $1,548,887 on Apr 01 ’24. The insider now owns 69,253 shares after completing the transaction at $67.09 per share. On Mar 26 ’24, another insider, Heery Christopher, who serves as the CHIEF MEDICAL OFFICER of the company, sold 5,450 shares for $69.11 each. As a result, the insider received 376,648 and left with 8,938 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 2904321280 and an Enterprise Value of 2273023744. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.33 while its Price-to-Book (P/B) ratio in mrq is 5.87. Its current Enterprise Value per Revenue stands at 20.604 whereas that against EBITDA is -25.877.
Stock Price History:
Over the past 52 weeks, ACLX has reached a high of $75.10, while it has fallen to a 52-week low of $30.74. The 50-Day Moving Average of the stock is -16.60%, while the 200-Day Moving Average is calculated to be 12.77%.
Shares Statistics:
The stock has traded on average 451.95K shares per day over the past 3-months and 485510 shares per day over the last 10 days, according to various share statistics. A total of 52.28M shares are outstanding, with a floating share count of 39.78M. Insiders hold about 25.35% of the company’s shares, while institutions hold 74.10% stake in the company. Shares short for ACLX as of 1711584000 were 3768604 with a Short Ratio of 8.34, compared to 1709164800 on 3430785. Therefore, it implies a Short% of Shares Outstanding of 3768604 and a Short% of Float of 7.9799999999999995.
Earnings Estimates
The company has AMLX analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.90, with high estimates of $98.25 and low estimates of $143.20.
Analysts are recommending an EPS of between $Technology and $Consumer Defensive for the fiscal current year, implying an average EPS of $Healthcare.
